Convolution-based approach for modeling the paliperidone extended release and Long-Acting Injectable (LAI) PK of once-, and three-monthly products administration and for optimizing the development of new LAI products
Crossref DOI link: https://doi.org/10.1007/s10928-022-09835-7
Published Online: 2022-12-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gomeni, Roberto
Bressolle-Gomeni, Françoise
Text and Data Mining valid from 2022-12-09
Version of Record valid from 2022-12-09
Article History
Received: 8 September 2022
Accepted: 28 November 2022
First Online: 9 December 2022
Declarations
:
: The authors declare that they have no conflict of interest.